Simulation-derived best practices for clustering clinical data.
Simulation-derived best practices for clustering clinical data.
复制标题
用于聚类临床数据的模拟衍生最佳实践。
DOI:
10.1016/j.jbi.2021.103788
复制
发表时间:
2021-06
影响因子:
4.5
通讯作者:
Brock, Guy
中科院分区:
文献类型:
--
作者:
Coombes, Caitlin E.;Liu, Xin;Abrams, Zachary B.;Coombes, Kevin R.;Brock, Guy
关键词:
Clustering analyses in clinical contexts hold promise to improve the understanding of patient phenotype and disease course in chronic and acute clinical medicine. However, work remains to ensure that solutions are rigorous, valid, and reproducible. In this paper, we evaluate best practices for dissimilarity matrix calculation and clustering on mixed-type, clinical data. We simulate clinical data to represent problems in clinical trials, cohort studies, and EHR data, including single-type datasets (binary, continuous, categorical) and 4 data mixtures. We test 5 single distance metrics (Jaccard, Hamming, Gower, Manhattan, Euclidean) and 3 mixed distance metrics (DAISY, Supersom, and Mercator) with 3 clustering algorithms (hierarchical (HC), k-medoids, self-organizing maps (SOM)). We quantitatively and visually validate by Adjusted Rand Index (ARI) and silhouette width (SW). We applied our best methods to two real-world data sets: (1) 21 features collected on 247 patients with chronic lymphocytic leukemia, and (2) 40 features collected on 6000 patients admitted to an intensive care unit. HC outperformed k-medoids and SOM by ARI across data types. DAISY produced the highest mean ARI for mixed data types for all mixtures except unbalanced mixtures dominated by continuous data. Compared to other methods, DAISY with HC uncovered superior, separable clusters in both real-world data sets. Selecting an appropriate mixed-type metric allows the investigator to obtain optimal separation of patient clusters and get maximum use of their data. Superior metrics for mixed-type data handle multiple data types using multiple, type-focused distances. Better subclassification of disease opens avenues for targeted treatments, precision medicine, clinical decision support, and improved patient outcomes.
登录
查看更多内容
影响因子:
10
作者:
Castaldi, Peter J.;Benet, Marta;Garcia-Aymerich, Judith
通讯作者:
Garcia-Aymerich, Judith
影响因子:
3.7
作者:
Egan, Brent M.;Sutherland, Susan E.;Sinopoli, Angelo
通讯作者:
Sinopoli, Angelo
影响因子:
1.3
作者:
Bose, Eliezer;Radhakrishnan, Kavita
通讯作者:
Radhakrishnan, Kavita
影响因子:
3.9
作者:
Ahmad, Amir;Khan, Shehroz S.
通讯作者:
Khan, Shehroz S.
影响因子:
9.8
作者:
Johnson AE;Pollard TJ;Shen L;Lehman LW;Feng M;Ghassemi M;Moody B;Szolovits P;Celi LA;Mark RG
通讯作者:
Mark RG